Nisa Investment Advisors, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Nisa Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$17.63 - $21.74 $493 - $608	28 Added 93.33%	58 $1,000
Q2 2023 Aug 11, 2023	SELL	$10.44 - $16.48 $135 - $214	-13 Reduced 30.23%	30 $0
Q3 2022 Nov 07, 2022	BUY	$9.76 - $13.41 $419 - $576	43 New	43 $1,000
Q1 2022 Apr 29, 2022	SELL	$9.3 - $12.37 $70,884 - $94,284	-7,622 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$10.39 - $15.15 $79,192 - $115,473	7,622 New	7,622 $86,000
Q1 2021 Apr 26, 2021	SELL	$16.68 - $23.97 $66,720 - $95,880	-4,000 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$14.8 - $21.15 $59,200 - $84,600	4,000 New	4,000 $71,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.